Latest news
BioAge Labs, Inc. Stock 12‑Month Price Target Cut to $35.62, Implies 224% Upside - TradingViewTradingView · Thu, 06 Aug 2026 17:20:09 GMTBioAge Labs, Inc. reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Wed, 05 Aug 2026 22:40:59 GMTBIOA: BGE-102 clinical trials advanced, net loss increased, and cash reserves remain strong - TradingViewTradingView · Wed, 05 Aug 2026 21:03:52 GMTBioAge Labs reports Q2 2026 net loss $26.1M, cash and securities $381.3M; BGE-102 Phase 2 dosing underway - TradingViewTradingView · Wed, 05 Aug 2026 21:03:15 GMTBioAge Labs, Inc. Q2 2026: Revenue $2.45M, EPS $(0.58) — 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 21:02:08 GMTPrice to earnings forward of BioAge Labs, Inc. – SWB:Y7G - TradingViewTradingView · Wed, 05 Aug 2026 12:40:11 GMTBIOA Q2'26 Earnings: revenue estimate is 1.50M USD - TradingViewTradingView · Wed, 05 Aug 2026 11:00:11 GMTWeekly Recap: ZEUS miss lifts BGE-102 and Analysts cut BIOA PTs, keep Buy - TradingViewTradingView · Mon, 03 Aug 2026 11:33:16 GMT